Nasdaq: HRTX
Heron Therapeutics insiders
The officers, directors and 10% owners of Heron Therapeutics, Inc. who hold the most stock, valued at the live HRTX price.
$0.26
HRTX today −$9K (−3.30%)
Market closed. Prices as of Nov 19, 4:04 PM ET
- Ranked insiders
- 1
- Their HRTX stock
- $14K
- Market value
- $50.3M
- Held by ranked insiders
- <0.1%
Insiders by value of HRTX holdings
SEC ownership page| # | Insider | Role | Shares | Value | Of company | Overall rank |
|---|---|---|---|---|---|---|
| 1 | Michael Kaseta | Director | 53,960 | $14K | <0.1% | 5352nd |
Only insiders worth at least $5 million in listed stock are ranked. Holdings come from each insider's latest Form 3, 4 or 5 for Heron Therapeutics; see each profile for the filing.